Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 975 to 1024 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, zeta type (ec 2.7.1.37) (npkc-zeta). [source:swissprot;acc:q05513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.987\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03426\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell activation wd repeat protein. [source:refseq;acc:nm\_139281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
243.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 5 (c-myc binding protein mm-1) (myc modulator 1). [source:swissprot;acc:q99471]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
228.953\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.421\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03402\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 6 (protein ke2). [source:swissprot;acc:o15212]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gcn5-like protein 1 (rt14 protein). [source:swissprot;acc:p78537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.027\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
130.289\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
134.713\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03396\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec6. [source:swissprot;acc:o60645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.398\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cirhin; testis expressed gene 292; cirrhosis, autosomal recessive 1a. [source:refseq;acc:nm\_032830]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
243.312\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03383\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pbk1 protein. [source:sptrembl;acc:o76021]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
235.353\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03382\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
116.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
120.654\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03379\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 5 (tfar19 protein) (tf-1 cell apoptosis related gene-19 protein). [source:swissprot;acc:o14737]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
233.402\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec5. [source:swissprot;acc:q96kp1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
116.771\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
120.707\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03371\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.459\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.338\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03369\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.461\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.343\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.462\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.345\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03367\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase rok1; atp-dependent rna helicase. [source:refseq;acc:nm\_007010]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
243.297\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.373\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichol-phosphate mannosyltransferase (ec 2.4.1.83) (dolichol- phosphate mannose synthase) (dolichyl-phosphate beta-d- mannosyltransferase) (mannose-p-dolichol synthase) (mpd synthase) (dpm synthase). [source:swissprot;acc:o60762]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.381\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.468\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.357\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03364\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.071\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03362\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
116.845\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
120.772\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03361\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2b (mad2-like 2) (hrev7). [source:swissprot;acc:q9ui95]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.656\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.547\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03345\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s32 (s32mt) (mrp-s32) (ptd007) (hspc204). [source:swissprot;acc:q9y6g3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear pore complex protein nup88 (nucleoporin nup88) (88 kda nuclear pore complex protein). [source:swissprot;acc:q99567]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 2, cytosolic (dh ic-2) (cytoplasmic dynein intermediate chain 2). [source:swissprot;acc:q13409]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.557\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03338\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vinculin (metavinculin). [source:swissprot;acc:p18206]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
225.167\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.922\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1003\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
238.725\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.059\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03318\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.448\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.232\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03307\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 73 kda subunit (cpsf 73 kda subunit). [source:swissprot;acc:q9ukf6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
116.524\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
120.375\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03305\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
162.055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
156.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03296\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1008\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein bing4. [source:swissprot;acc:o15213]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
243.227\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03292\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydropyrimidine dehydrogenase [nadp+] precursor (ec 1.3.1.2) (dpd) (dhpdhase) (dihydrouracil dehydrogenase) (dihydrothymine dehydrogenase). [source:swissprot;acc:q12882]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.116\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.823\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03288\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1010\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal carnitine octanoyltransferase (ec 2.3.1.-) (cot). [source:swissprot;acc:q9ukg9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.523\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.648\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03264\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 2 (130 kda retinoblastoma-associated protein) (prb2) (p130) (rbr-2). [source:swissprot;acc:q08999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.026\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03253\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1012\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 1 (107 kda retinoblastoma-associated protein) (prb1) (p107). [source:swissprot;acc:p28749]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.021\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03252\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1013\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein bap28. [source:swissprot;acc:q9h583]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
244.312\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03239\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1014\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis antagonizing transcription factor. [source:refseq;acc:nm\_012138]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
243.045\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.422\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03238\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1015\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 1; ww domain-containing protein 3; atrophin-1 interacting protein 3. [source:refseq;acc:nm\_004742]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03236\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1016\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.369\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.561\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03233\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1017\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.365\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.558\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1018\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.361\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.554\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1019\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase-related gene segment, exon 5 (fragment). [source:sptrembl;acc:q15677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.302\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.409\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03215\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1020\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dopachrome tautomerase precursor (ec 5.3.3.12) (dt) (dct) (dopachrome delta-isomerase) (tyrosinase-related protein 2) (trp-2) (trp2). [source:swissprot;acc:p40126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.28\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.03205\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1021\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.278\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.03204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1022\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cystathionine beta-synthase (ec 4.2.1.22) (serine sulfhydrase) (beta-thionase). [source:swissprot;acc:p35520]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
205.632\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
199.266\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03195\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1023\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein rhoc (h9). [source:swissprot;acc:p08134]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1024\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thiosulfate sulfurtransferase (ec 2.8.1.1) (rhodanese). [source:swissprot;acc:q16762]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/